CJ Bioscience, Inc. (KOSDAQ: 311690)
South Korea
· Delayed Price · Currency is KRW
10,120
0.00 (0.00%)
Dec 20, 2024, 9:00 AM KST
CJ Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 92,219 | 147,076 | 170,481 | 286,048 | 199,288 | 143,216 | |
| Market Cap Growth | -21.53% | -13.73% | -40.40% | 43.53% | 39.15% | - | |
| Enterprise Value | 58,506 | 116,989 | 139,502 | 291,080 | 185,214 | 129,115 | |
| Last Close Price | 10120.00 | 16140.00 | 24887.51 | 41793.85 | 43939.33 | 32267.94 | |
| PS Ratio | 23.26 | 26.38 | 41.84 | 65.56 | 37.52 | 29.94 | |
| PB Ratio | 1.92 | 2.06 | 3.43 | 3.26 | 5.78 | 4.64 | |
| P/TBV Ratio | 3.08 | 2.49 | 3.51 | 3.26 | 5.80 | 4.66 | |
| EV/Sales Ratio | 14.75 | 20.98 | 34.24 | 66.72 | 34.87 | 26.99 | |
| Debt / Equity Ratio | 0.18 | 0.12 | 0.58 | 0.27 | 1.04 | 0.02 | |
| Asset Turnover | 0.05 | 0.06 | 0.04 | 0.05 | 0.10 | 0.21 | |
| Inventory Turnover | 17.39 | 32.50 | 24.89 | 10.67 | 13.27 | 17.34 | |
| Quick Ratio | 3.01 | 4.38 | 1.43 | 3.39 | 13.19 | 13.57 | |
| Current Ratio | 3.11 | 4.43 | 1.46 | 3.42 | 13.68 | 13.73 | |
| Return on Equity (ROE) | -36.64% | -37.83% | -50.78% | -31.51% | -26.82% | -20.88% | |
| Return on Assets (ROA) | -24.98% | -21.95% | -20.00% | -6.66% | -9.94% | -12.13% | |
| Return on Capital (ROIC) | -29.09% | -25.26% | -21.82% | -6.94% | -10.45% | -13.33% | |
| Earnings Yield | -23.43% | -15.58% | -20.48% | -6.74% | -4.40% | -3.03% | |
| FCF Yield | -29.65% | -20.28% | -14.73% | -3.28% | -10.03% | -2.05% | |
| Buyback Yield / Dilution | -45.44% | -20.52% | -38.23% | -10.14% | -16.93% | -2.78% | |
| Total Shareholder Return | -45.44% | -20.52% | -38.23% | -10.14% | -16.93% | -2.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.